FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1986534053> ?p ?o ?g. }

• W1986534053 endingPage "261" @default.
• W1986534053 startingPage "255" @default.
• W1986534053 abstract "To determine the impact on minimal residual disease by switching to imatinib chronic phase chronic myeloid leukaemia (CP-CML) patients responsive to interferon-alpha (IFNα), in stable complete cytogenetic response (CCR) but with persistent PCR positivity. Twenty-six Philadelphia positive (Ph+) CML patients in stable CCR after IFNα but persistently positive at PCR analysis during this treatment, were given imatinib mesylate at standard dose. At enrolment into the study, median IFN treatment and CCR duration were 88 months (range 15–202) and 73 months (range 10–148), respectively. Imatinib treatment resulted in a progressive and consistent decline of the residual disease as measured by quantitative PCR (RQ-PCR) in all but one of the 26 patients; at the end of follow-up, after a median of 32 months (range 21–49) of treatment, a major molecular response (BCR/ABL levels <0.1) was reached in 20 patients (77%), and BCR/ABL transcripts were undetectable in 13 (50%). The achievement of molecular response was significantly correlated with post-IFN baseline transcript level (mean 1.194 for patients achieving complete molecular response versus 18.97 for those who did not; p < 0.001), but not with other clinical/biological disease characteristics. These results indicate that patients induced into CCR by IFN treatment represent a subset with very favourable prognosis, which can significantly improve molecular response with imatinib and further support investigative treatment schedules combining these two drugs." @default.
• W1986534053 created "2016-06-24" @default.
• W1986534053 creator A5004650158 @default.
• W1986534053 creator A5006023644 @default.
• W1986534053 creator A5008958861 @default.
• W1986534053 creator A5009095647 @default.
• W1986534053 creator A5014448665 @default.
• W1986534053 creator A5014873864 @default.
• W1986534053 creator A5032696007 @default.
• W1986534053 creator A5037698212 @default.
• W1986534053 creator A5038749239 @default.
• W1986534053 creator A5049790333 @default.
• W1986534053 creator A5057084037 @default.
• W1986534053 creator A5059488532 @default.
• W1986534053 creator A5062437293 @default.
• W1986534053 creator A5085402984 @default.
• W1986534053 creator A5089760320 @default.
• W1986534053 date "2008-02-01" @default.
• W1986534053 modified "2023-09-24" @default.
• W1986534053 title "Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate" @default.
• W1986534053 cites W188630774 @default.
• W1986534053 cites W1894088929 @default.
• W1986534053 cites W1988399039 @default.
• W1986534053 cites W1988689365 @default.
• W1986534053 cites W2008649212 @default.
• W1986534053 cites W2011474502 @default.
• W1986534053 cites W2011672574 @default.
• W1986534053 cites W2014316424 @default.
• W1986534053 cites W2018279800 @default.
• W1986534053 cites W2028959752 @default.
• W1986534053 cites W2036862498 @default.
• W1986534053 cites W2045180507 @default.
• W1986534053 cites W2058558811 @default.
• W1986534053 cites W2068977368 @default.
• W1986534053 cites W2076372887 @default.
• W1986534053 cites W2076736727 @default.
• W1986534053 cites W2079517811 @default.
• W1986534053 cites W2107268345 @default.
• W1986534053 cites W2120033838 @default.
• W1986534053 cites W2128738046 @default.
• W1986534053 cites W2131656137 @default.
• W1986534053 cites W2140191827 @default.
• W1986534053 cites W2151486690 @default.
• W1986534053 cites W2157743993 @default.
• W1986534053 cites W2277608633 @default.
• W1986534053 cites W2329648702 @default.
• W1986534053 cites W2337277825 @default.
• W1986534053 cites W2394816133 @default.
• W1986534053 cites W2508058084 @default.
• W1986534053 doi "https://doi.org/10.1016/j.leukres.2007.06.008" @default.
• W1986534053 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17692911" @default.
• W1986534053 hasPublicationYear "2008" @default.
• W1986534053 type Work @default.
• W1986534053 sameAs 1986534053 @default.
• W1986534053 citedByCount "13" @default.
• W1986534053 countsByYear W19865340532012 @default.
• W1986534053 countsByYear W19865340532013 @default.
• W1986534053 crossrefType "journal-article" @default.
• W1986534053 hasAuthorship W1986534053A5004650158 @default.
• W1986534053 hasAuthorship W1986534053A5006023644 @default.
• W1986534053 hasAuthorship W1986534053A5008958861 @default.
• W1986534053 hasAuthorship W1986534053A5009095647 @default.
• W1986534053 hasAuthorship W1986534053A5014448665 @default.
• W1986534053 hasAuthorship W1986534053A5014873864 @default.
• W1986534053 hasAuthorship W1986534053A5032696007 @default.
• W1986534053 hasAuthorship W1986534053A5037698212 @default.
• W1986534053 hasAuthorship W1986534053A5038749239 @default.
• W1986534053 hasAuthorship W1986534053A5049790333 @default.
• W1986534053 hasAuthorship W1986534053A5057084037 @default.
• W1986534053 hasAuthorship W1986534053A5059488532 @default.
• W1986534053 hasAuthorship W1986534053A5062437293 @default.
• W1986534053 hasAuthorship W1986534053A5085402984 @default.
• W1986534053 hasAuthorship W1986534053A5089760320 @default.
• W1986534053 hasConcept C104317684 @default.
• W1986534053 hasConcept C126322002 @default.
• W1986534053 hasConcept C138626823 @default.
• W1986534053 hasConcept C143998085 @default.
• W1986534053 hasConcept C170493617 @default.
• W1986534053 hasConcept C203014093 @default.
• W1986534053 hasConcept C2776178377 @default.
• W1986534053 hasConcept C2776694085 @default.
• W1986534053 hasConcept C2777583451 @default.
• W1986534053 hasConcept C2778461978 @default.
• W1986534053 hasConcept C2778729363 @default.
• W1986534053 hasConcept C2778822529 @default.
• W1986534053 hasConcept C2778904597 @default.
• W1986534053 hasConcept C2779134260 @default.
• W1986534053 hasConcept C2779823535 @default.
• W1986534053 hasConcept C2909179924 @default.
• W1986534053 hasConcept C3019096185 @default.
• W1986534053 hasConcept C3019892230 @default.
• W1986534053 hasConcept C43907098 @default.
• W1986534053 hasConcept C48023723 @default.
• W1986534053 hasConcept C55493867 @default.
• W1986534053 hasConcept C71924100 @default.
• W1986534053 hasConcept C86803240 @default.
• W1986534053 hasConcept C90924648 @default.
• W1986534053 hasConceptScore W1986534053C104317684 @default.

• next